Stock Track | Illumina Soars 5.14% Intraday on Multiple Product Launches Including Whole-Genome Sequencing Workflow and FireflyGO Platform

Stock Track05-29

Illumina's stock surged 5.14% during intraday trading on Thursday, reflecting significant investor optimism following a series of product announcements from the company.

The genomics company launched a whole-genome sequencing research workflow for molecular residual disease detection, which is expected to support residual disease detection and cancer genomic profiling. The workflow can complete processing in about five days and targets analytical sensitivity down to 10 parts per million for certain tumors.

Additionally, Illumina partnered with SPT Labtech to launch fireflyGO, a benchtop automation platform for targeted oncology NGS library preparation. The system integrates with Illumina's MiSeq i100 Series to reduce manual steps and improve reproducibility. The company also introduced the first distributed whole-genome sequencing solution for highly sensitive MRD research and announced a new complete solution for MRD research based on whole-genome sequencing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1132049518?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 01:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132049518","market":"us","top_or_hot":-1,"title":"Stock Track | Illumina Soars 5.14% Intraday on Multiple Product Launches Including Whole-Genome Sequencing Workflow and FireflyGO Platform","media":"Stock Track","content":"<p>Illumina's stock surged 5.14% during intraday trading on Thursday, reflecting significant investor optimism following a series of product announcements from the company.</p><p>The genomics company launched a whole-genome sequencing research workflow for molecular residual disease detection, which is expected to support residual disease detection and cancer genomic profiling. The workflow can complete processing in about five days and targets analytical sensitivity down to 10 parts per million for certain tumors.</p><p>Additionally, Illumina partnered with SPT Labtech to launch fireflyGO, a benchtop automation platform for targeted oncology NGS library preparation. The system integrates with Illumina's MiSeq i100 Series to reduce manual steps and improve reproducibility. The company also introduced the first distributed whole-genome sequencing solution for highly sensitive MRD research and announced a new complete solution for MRD research based on whole-genome sequencing.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Illumina Soars 5.14% Intraday on Multiple Product Launches Including Whole-Genome Sequencing Workflow and FireflyGO Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Illumina Soars 5.14% Intraday on Multiple Product Launches Including Whole-Genome Sequencing Workflow and FireflyGO Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-29 01:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Illumina's stock surged 5.14% during intraday trading on Thursday, reflecting significant investor optimism following a series of product announcements from the company.</p><p>The genomics company launched a whole-genome sequencing research workflow for molecular residual disease detection, which is expected to support residual disease detection and cancer genomic profiling. The workflow can complete processing in about five days and targets analytical sensitivity down to 10 parts per million for certain tumors.</p><p>Additionally, Illumina partnered with SPT Labtech to launch fireflyGO, a benchtop automation platform for targeted oncology NGS library preparation. The system integrates with Illumina's MiSeq i100 Series to reduce manual steps and improve reproducibility. The company also introduced the first distributed whole-genome sequencing solution for highly sensitive MRD research and announced a new complete solution for MRD research based on whole-genome sequencing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ILMN","symbol_name":"Illumina","start_time":0,"source_url":"","article_id":"1132049518","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132049518","pubTimestamp":1779989974,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Illumina's stock surged 5.14% during intraday trading on Thursday, reflecting significant investor optimism following a series of product announcements from the company.The genomics company launched...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ILMN":"Illumina"},"translate_title":"个股追踪|Illumina盘中大涨5.14%全基因组测序工作流程和FireflyGO平台等多款产品发布","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ILMN":1},"content_text":"Illumina's stock surged 5.14% during intraday trading on Thursday, reflecting significant investor optimism following a series of product announcements from the company.The genomics company launched a whole-genome sequencing research workflow for molecular residual disease detection, which is expected to support residual disease detection and cancer genomic profiling. The workflow can complete processing in about five days and targets analytical sensitivity down to 10 parts per million for certain tumors.Additionally, Illumina partnered with SPT Labtech to launch fireflyGO, a benchtop automation platform for targeted oncology NGS library preparation. The system integrates with Illumina's MiSeq i100 Series to reduce manual steps and improve reproducibility. The company also introduced the first distributed whole-genome sequencing solution for highly sensitive MRD research and announced a new complete solution for MRD research based on whole-genome sequencing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1132049518","isCrawlerRequest":true}